GlassScriptPhysician profile
Klas D Miller
NPI 1417122706
$674.15
in general payments reported to CMS, 2019-2025
15 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.65 · 2020: $85.67 · 2021: $186 · 2022: $125 · 2023: $20.43 · 2024: $110 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.59 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $109.29 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $68.77 | 2020-2021 | |
| Ethicon US, LLC | $48.97 | 2020-2021 | |
| Myovant Sciences INC. | $45.10 | 2021-2022 | |
| Medtronic, INC. | $26.32 | 2022 | |
| Evofem Biosciences, INC. | $24.82 | 2021 | |
| Astellas Pharma US INC | $23.46 | 2024 | Veozah |
| Dexcom, INC. | $21.81 | 2025 | Dexcom G6 Transmitter |
| Heron Therapeutics, INC. | $20.01 | 2022 | |
| Abbott Laboratories | $19.71 | 2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $19.00 | 2025 | Gardasil 9 |
| Biogen, INC. | $14.09 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $13.17 | 2024 | Slynd |
| Therapeuticsmd, INC. | $12.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klas Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.